-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SIq2/7Ryb+WXsiuQYrjoLoyMaWL23rlykWQkBAsb3ZU2rEcjbY0lMahx1tJim5rw TsomH33rk6zlbmSNE7RV0g== 0001193125-05-094105.txt : 20050503 0001193125-05-094105.hdr.sgml : 20050503 20050503171701 ACCESSION NUMBER: 0001193125-05-094105 CONFORMED SUBMISSION TYPE: SC TO-T/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20050503 DATE AS OF CHANGE: 20050503 GROUP MEMBERS: NECTARINE AQUISITION CORP. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NEIGHBORCARE INC CENTRAL INDEX KEY: 0000874265 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 061132947 STATE OF INCORPORATION: PA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC TO-T/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-44049 FILM NUMBER: 05796074 BUSINESS ADDRESS: STREET 1: NEIGHBORCARE, INC. STREET 2: 601 EAST PRATT STREET THIRD FLOOR CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: (410) 528-7300 MAIL ADDRESS: STREET 1: NEIGHBORCARE, INC. STREET 2: 601 EAST PRATT STREET THIRD FLOOR CITY: BALTIMORE STATE: MD ZIP: 21202 FORMER COMPANY: FORMER CONFORMED NAME: GENESIS HEALTH VENTURES INC /PA DATE OF NAME CHANGE: 19950214 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE INC CENTRAL INDEX KEY: 0000353230 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 311001351 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC TO-T/A BUSINESS ADDRESS: STREET 1: 100 E RIVERCENTER BLVD STREET 2: STE 1600 CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 6063923300 MAIL ADDRESS: STREET 1: 100 E RIVERCENTER BLVD STREET 2: STE 1600 CITY: COVINGTON STATE: KY ZIP: 41101 SC TO-T/A 1 dsctota.htm AMENDMENT NO. 25 TO SCHEDULE TO Amendment No. 25 to Schedule TO

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

 

SCHEDULE TO

(Rule 14d-100)

TENDER OFFER STATEMENT

UNDER

SECTION 14(d)(1) OR SECTION 13(e)(1)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

AMENDMENT NO. 25

 


 

NeighborCare, Inc.

(Name of Subject Company (Issuer))

 


 

Omnicare, Inc.

Nectarine Acquisition Corp.

(Names of Filing Persons (Offerors))

 

Common Stock, par value $0.02 per share

(Including the Associated Preferred Stock Purchase Rights)

(Title of Class of Securities)

 

64015Y104

(CUSIP Number of Common Stock)

 


 

 

Joel F. Gemunder

President and Chief Executive Officer

Omnicare, Inc.

100 East RiverCenter Boulevard

Covington, Kentucky 41011

(859) 392-3300

(Name, Address and Telephone Number of Person Authorized to Receive Notices and

Communications on Behalf of Filing Persons)

 


 

Copies to:

Morton A. Pierce, Esq.

Michael J. Aiello, Esq.

Dewey Ballantine LLP

1301 Avenue of the Americas

New York, New York 10019

(212) 259-8000

 


 

 

CALCULATION OF FILING FEE

 

Transaction Valuation*


 

Amount of Filing Fee


$1,386,439,110   $175,662

 

* Estimated for purposes of calculating the amount of the filing fee only. This amount assumes the purchase of (i) 43,672,753 shares of the common stock, par value $0.02, including the associated preferred stock purchase rights, of NeighborCare, Inc. (“Shares”), representing all of the outstanding Shares as of May 11, 2004 (less 100 Shares owned by Omnicare, Inc.), (ii) 259,980 Shares to be issued in connection with NeighborCare’s joint plan of reorganization confirmed by the Bankruptcy Court on September 20, 2001 and (iii) 2,281,904 Shares reserved for issuance upon the exercise of outstanding options to purchase Shares. The number of outstanding shares and shares reserved for issuance in connection with NeighborCare’s joint plan of reorganization is contained in the Quarterly Report on Form 10-Q filed by NeighborCare on May 14, 2004. The number of outstanding shares reserved for issuance upon the exercise of options is as disclosed in the transcript of NeighborCare, Inc.’s Second Quarter 2004 earnings conference call on May 13, 2004.

 



x Check box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

Amount Previously Paid: $175,662

  Filing party: Omnicare, Inc.

Form or Registration No.: SC TO

  Date Filed: June 4, 2004

 

¨ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

 

Check the appropriate boxes below to designate any transactions to which the statement relates:

 

  x third-party tender offer subject to Rule 14d-1

 

  ¨ issuer tender offer subject to Rule 13e-4

 

  ¨ going private transaction subject to Rule 13e-3

 

  ¨ amendment to Schedule 13D under Rule 13d-2

 

Check the following box if the filing is a final amendment reporting the results of the tender offer  ¨


This Amendment No. 25 amends and supplements the Tender Offer Statement on Schedule TO filed with the Securities and Exchange Commission (“the Commission”) on June 4, 2004 (the “Schedule TO”) by Omnicare, Inc., a Delaware corporation (“Omnicare”), and Nectarine Acquisition Corp., a Delaware corporation (“Purchaser”) and a wholly owned subsidiary of Omnicare. The Schedule TO relates to a tender offer by Purchaser to purchase all of the outstanding shares of common stock, par value $0.02 per share, including the associated preferred stock purchase rights, of NeighborCare, Inc. (the “Company”) for a purchase price of $30.00 per share, net to the seller in cash, without interest thereon, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated June 4, 2004 (the “Offer to Purchase”), and in the related Letter of Transmittal (the “Letter of Transmittal” which, together with the Offer to Purchase, as hereby or hereafter amended or supplemented from time to time, constitute the “Offer”). Copies of the Offer to Purchase and the related Letter of Transmittal are filed with the Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively. Capitalized terms used and not defined herein shall have meanings assigned such terms in the Offer to Purchase and the Schedule TO.

 

Item 12. Exhibits.

 

Item 12 is hereby amended and supplemented with the following information:

 

Exhibit (a)(1)(GG) Excerpt from the Transcript of Omnicare, Inc.’s First Quarter 2005 Conference Call, dated April 28, 2005.


SIGNATURE

 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: May 3, 2005

 

OMNICARE, INC.

By:  

/s/    Cheryl D. Hodges

Name:

  Cheryl D. Hodges

Title:

  Senior Vice President and Secretary

NECTARINE ACQUISITION CORP.

By:  

/s/    Cheryl D. Hodges

Name:

  Cheryl D. Hodges

Title:

  Secretary


EXHIBIT INDEX

 

(a )(1)(A)   Offer to Purchase dated June 4, 2004.*
(a )(1)(B)   Letter of Transmittal.*
(a )(1)(C)   Notice of Guaranteed Delivery.*
(a )(1)(D)   Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.*
(a )(1)(E)   Letter to Clients for use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.*
(a )(1)(F)   Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9.*
(a )(1)(G)   Summary Advertisement, published June 4, 2004.*
(a )(1)(H)   Press release issued by Omnicare on June 4, 2004.*
(a )(1)(I)   Selected material from a presentation of Omnicare, Inc. at the Goldman Sachs Healthcare Conference on June 9, 2004 at the Ritz-Carlton Laguna Niguel, Dana Point, California.*
(a )(1)(J)   Press release issued by Omnicare, Inc. on June 14, 2004.*
(a )(1)(K)   Press release issued by Omnicare, Inc. on June 15, 2004.*
(a )(1)(L)   Selected material from a presentation of Omnicare, Inc. at the Jefferies & Company, Inc. Specialty and Post-Acute Services Conference on June 15, 2004 at the St. Regis Hotel, New York, New York.*
(a )(1)(M)   Press release issued by Omnicare, Inc. on June 25, 2004.*
(a )(1)(N)   Press release issued by Omnicare, Inc. on July 13, 2004.*
(a )(1)(O)   Press release issued by Omnicare, Inc. on July 26, 2004.*
(a )(1)(P)   Excerpts from the Transcript of Omnicare, Inc.’s Second Quarter 2004 Conference Call, dated July 26, 2004.*
(a )(1)(Q)   Press release issued by Omnicare, Inc. on July 30, 2004.*
(a )(1)(R)   Selected material from a presentation of Omnicare, Inc. at the Omnicare, Inc. Management Conference on August 14, 2004.*
(a )(1)(S)   Press release issued by Omnicare, Inc. on September 1, 2004.*
(a )(1)(T)   Press release issued by Omnicare, Inc. on October 1, 2004.*
(a )(1)(U)   Press release issued by Omnicare, Inc. on November 1, 2004.*
(a )(1)(V)   Excerpt from the Transcript of Omnicare, Inc.’s Third Quarter 2004 Conference Call, dated October 28, 2004.*
(a )(1)(W)   Press release issued by Omnicare, Inc. on December 1, 2004.*
(a )(1)(X)   Press release issued by Omnicare, Inc. on December 23, 2004.*
(a )(1)(Y)   Press release issued by Omnicare, Inc. on January 7, 2005.*
(a )(1)(Z)   Selected material from a presentation of Omnicare, Inc. at the JPMorgan 23rd Annual Healthcare Conference on January 13, 2005 at the Westin St. Francis Hotel, San Francisco, California.*
(a )(1)(AA)   Press release issued by Omnicare, Inc. on February 7, 2005.*
(a )(1)(BB)   Excerpts from the Transcript of Omnicare, Inc.’s Fourth Quarter 2004 Conference Call, dated February 24, 2005.*
(a )(1)(CC)   Press release issued by Omnicare, Inc. on March 4, 2005.*
(a )(1)(DD)   Press release issued by Omnicare, Inc. on April 1, 2005.*
(a )(1)(EE)   Press release issued by Omnicare, Inc. on April 4, 2005.*
(a )(1)(FF)   Press release issued by Omnicare, Inc. on April 29, 2005.*
(a )(1)(GG)   Excerpt from the Transcript of Omnicare, Inc.’s First Quarter 2005 Conference Call, dated April 28, 2005.
(b )(1)   Commitment Letter Agreement among JPMorgan Chase Bank, J.P. Morgan Securities Inc., Lehman Commercial Paper Inc., Lehman Brothers Inc., SunTrust Bank, SunTrust Capital Markets, Inc., Canadian Imperial Bank of Commerce, CIBC World Markets Corp., Merrill Lynch Bank USA, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Omnicare Inc., dated June 3, 2004.*
(b )(2)   Commitment Letter Amendment, among JPMorgan Chase Bank, N.A., J.P. Morgan Securities, Inc., Lehman Commercial Paper Inc., Lehman Brothers Inc., SunTrust Bank, SunTrust Capital Markets, Inc., Canadian Imperial Bank of Commerce, CIBC World Markets Corp., Merrill Lynch Bank USA, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Omnicare, Inc., dated April 28, 2005.*
(d )   None.
(g )   None.
(h )   None.

 

* previously filed
EX-99.(A)(1)(GG) 2 dex99a1gg.htm EXCERPT FROM THE TRANSCRIPT OF OMNICARE, INC.'S FIRST QUARTER CONFERENCE CALL Excerpt from the Transcript of Omnicare, Inc.'s First Quarter Conference Call

Exhibit (a)(1)(GG)

 

 

Excerpt from the Transcript of Omnicare, Inc.’s First Quarter 2005 Conference Call

 

April 28, 2005


 

 

Mr. Joel Gemunder:

 

Now, before I turn the call over to Dave and Cheryl for their comments, let me say a word about our tender [offer for] NeighborCare. As you know, we are continuing to work with the [FTC] to complete their review process. We continue to believe that this is a compelling combination. It represents an excellent, strategic fit and our $30 per share cash offer provides a unique opportunity for NeighborCare shareholders to realize maximum value for their shares immediately. And we of course would like to meet with the NeighborCare management and its Board and are willing to discuss all aspects of our offer. While we hope to be able to negotiate a deal with NeighborCare sooner rather than later, we have proposed a slate of three highly qualified independent Directors for election at NeighborCare’s upcoming shareholders meeting.

 

If necessary, this slate in our view will ensure that the interest[s] of NeighborCare shareholders, which have been made quite clear through the tenders, are well represented. In any case, we remain confident in the ability to consummate the offer. We are a determined, disciplined buyer and we continue to believe that this transaction makes compelling business sense. And that is all we have to say on this matter today. And much as I like to talk I won’t be taking questions on the subject.

-----END PRIVACY-ENHANCED MESSAGE-----